EUVIMEDEUVIMED entdecken
Crossref

Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism

Hiroki Kobayashi, Yoshihiro Nakamura, Masanori Abe, Akiyo Tanabe, Masakatsu Sone, Takuyuki Katabami, Isao Kurihara, Takamasa Ichijo, Mika Tsuiki, Shoichiro Izawa, Norio Wada, Takashi Yoneda und 8 weitere

Endocrine Journal · 2023

DOI: 10.1507/endocrj.ej22-0585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2023. Verfasst von Hiroki Kobayashi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Hypertension, and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan. Hauptthemen laut MEDLINE: Hypokalemia, Hyperaldosteronism, Hypertension. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypokalemiaHyperaldosteronismHypertensionHumansAldosteroneRetrospective StudiesCaptoprilSaline SolutionImmunoassayRenin

Stichwörter der Autor:innen

Novel chemiluminescent enzyme immunoassayPlasma aldosterone concentrationPrimary aldosteronism

Substanzen

AldosteroneCaptoprilSaline SolutionRenin

Autor:innen und Institutionen

  • Division of Nephrology, Hypertension, and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan.
  • Division of Endocrinology, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
  • Division of Metabolism and Endocrinology, Department of Internal Medicine, St Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama 241-0811, Japan.
  • Department of Medical Education, National Defense Medical College, Tokorozawa 359-8513, Japan.
  • Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Zitieren

APA

Kobayashi, H., Nakamura, Y., Abe, M., Tanabe, A., Sone, M., Katabami, T., Kurihara, I., Ichijo, T., Tsuiki, M., Izawa, S., Wada, N., Yoneda, T., Takahashi, K., Tamura, K., Ogawa, Y., Inagaki, N., Yamamoto, K., Rakugi, H., Naruse, M., & JPAS/JRAS Study Group (2023). Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism. Endocrine Journal. https://doi.org/10.1507/endocrj.ej22-0585

Vancouver

Kobayashi H, Nakamura Y, Abe M, Tanabe A, Sone M, Katabami T, et al. Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism. Endocrine Journal. 2023. doi:10.1507/endocrj.ej22-0585

BibTeX
@article{Kobayashi2023,
  author = {Kobayashi, Hiroki and Nakamura, Yoshihiro and Abe, Masanori and Tanabe, Akiyo and Sone, Masakatsu and Katabami, Takuyuki and Kurihara, Isao and Ichijo, Takamasa and Tsuiki, Mika and Izawa, Shoichiro and Wada, Norio and Yoneda, Takashi and Takahashi, Katsutoshi and Tamura, Kouichi and Ogawa, Yoshihiro and Inagaki, Nobuya and Yamamoto, Koichi and Rakugi, Hiromi and Naruse, Mitsuhide and JPAS/JRAS Study Group, JPAS/JRAS Study Group},
  title = {Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism},
  journal = {Endocrine Journal},
  year = {2023},
  doi = {10.1507/endocrj.ej22-0585}
}
Kostenlos starten →